Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.25 $4.50 Thursday, 9th May 2024 AVXL stock ended at $3.88. This is 4.58% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 9.32% from a day low at $3.60 to a day high of $3.93.
90 days $3.25 $6.15
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Nov 25, 2016 $3.74 $3.88 $3.64 $3.88 575 736
Nov 23, 2016 $3.63 $3.85 $3.31 $3.75 1 972 180
Nov 22, 2016 $3.94 $4.00 $3.38 $3.40 4 879 133
Nov 21, 2016 $3.28 $3.33 $3.17 $3.29 280 531
Nov 18, 2016 $3.20 $3.28 $3.20 $3.28 245 314
Nov 17, 2016 $3.15 $3.28 $3.11 $3.20 218 458
Nov 16, 2016 $3.28 $3.35 $3.17 $3.22 378 335
Nov 15, 2016 $3.21 $3.27 $3.19 $3.26 256 786
Nov 14, 2016 $3.32 $3.48 $3.17 $3.21 441 813
Nov 11, 2016 $3.20 $3.30 $3.17 $3.27 381 581
Nov 10, 2016 $3.33 $3.33 $3.12 $3.21 476 320
Nov 09, 2016 $2.90 $3.27 $2.82 $3.23 740 343
Nov 08, 2016 $2.88 $3.10 $2.88 $3.01 468 935
Nov 07, 2016 $2.94 $2.94 $2.85 $2.91 289 900
Nov 04, 2016 $2.78 $2.92 $2.77 $2.84 332 500
Nov 03, 2016 $2.77 $2.98 $2.77 $2.77 371 000
Nov 02, 2016 $3.07 $3.07 $2.76 $2.78 653 300
Nov 01, 2016 $2.93 $3.08 $2.79 $3.06 663 100
Oct 31, 2016 $2.94 $2.96 $2.76 $2.79 434 800
Oct 28, 2016 $2.91 $3.05 $2.86 $2.96 443 600
Oct 27, 2016 $3.08 $3.09 $2.82 $2.95 938 700
Oct 26, 2016 $3.10 $3.13 $3.06 $3.08 442 400
Oct 25, 2016 $3.29 $3.34 $3.10 $3.13 500 900
Oct 24, 2016 $3.34 $3.34 $3.25 $3.29 354 900
Oct 21, 2016 $3.30 $3.36 $3.28 $3.33 467 900
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT